Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pred Forte in chronic central serous chorioretinopathy
NL-OMON51739Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic central serous chorioretinopathy (CSCR) comparing Pred Forte eye drops with Placebo eye drops (2 arms). Started Feb 2023; status: recruiting.
02
Drugs
prednisolone
03
Conditions
Chronic central serous chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NL-OMON51739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51739.